Related Experiment Videos
B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation
Jacqueline William1, Chad Euler, Nicole Primarolo
1Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|February 4, 2006
Summary
Normal B cells expressing rheumatoid factor (RF) are activated by self-antigens. Two new regulatory checkpoints prevent autoantibody formation, but these fail in autoimmune diseases.
Area of Science:
- Immunology
- Autoimmunity
- B cell biology
Background:
- Autoreactive B cells are typically regulated by deletion, receptor editing, or anergy.
- Rheumatoid factor (RF)-expressing B cells in normal mice do not secrete autoantibodies and were thought to be quiescent.
- These autoreactive B cells are constitutively activated by self-antigens.
Purpose of the Study:
- To investigate the regulation of RF-expressing B cells in normal and autoimmune settings.
- To identify novel checkpoints controlling autoreactive B cell activation and autoantibody production.
Main Methods:
- Comparative analysis of B cell populations in normal (BALB/c) and autoimmune mice.
- Assessment of germinal center (GC) formation, B cell expansion, selection, and antibody-forming cell (AFC) generation.
Main Results:
- RF B cells in normal mice form GCs but few AFCs, indicating a regulatory checkpoint.
- Autoimmune mice readily generate RF AFCs, suggesting a failure of this checkpoint.
- Autoantigen-specific RF GCs in normal mice exhibit impaired B cell expansion and selection compared to autoimmune mice.
- Two novel checkpoints are identified: one preventing AFC formation post-GC entry, and another impairing GC selection.
Conclusions:
- Normal mice possess regulatory checkpoints that prevent autoantibody production from activated autoreactive B cells.
- These checkpoints involve limitations on germinal center B cell selection and differentiation into antibody-forming cells.
- Failure of these regulatory checkpoints contributes to autoimmunity.